SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Sean McCarthy will participate on a panel at the BIO International Convention in San Diego, CA titled "New Models for External Innovation by Pharma"
News | 06. 17. 2008
